Bitdeer Technologies
BTDR
Mawson Infrastructure
MIGI
Digihost Technology
DGHI
Canaan
CAN
Strategy
MSTR
US Stock MarketDetailed Quotes
ENTA Enanta Pharmaceuticals
- 8.090
- -0.400-4.71%
Close Feb 26 16:00 ET
- 8.090
- 0.0000.00%
Post 20:01 ET
172.58MMarket Cap-1.63P/E (TTM)
8.640High7.960Low377.15KVolume8.500Open8.490Pre Close3.11MTurnover2.64%Turnover RatioLossP/E (Static)21.33MShares17.80052wk High1.54P/B115.63MFloat Cap4.71052wk Low--Dividend TTM14.29MShs Float127.770Historical High--Div YieldTTM8.01%Amplitude4.710Historical Low8.258Avg Price1Lot Size
About Enanta Pharmaceuticals Company
Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.
Company Profile
SymbolENTA
Company NameEnanta Pharmaceuticals
Listing DateMar 21, 2013
Issue Price14.00
CEODr. Jay R. Luly, PhD
MarketNASDAQ
Employees131
Fiscal Year Ends09-30
Address4 Kingsbury Avenue
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-607-0800
Websitehttp://www.enanta.com
Company Executives
- Name
- Position
- Salary
- Dr. Jay R. Luly, PhD
- Director, President and Chief Executive Officer
- 2.70M
- Matthew P. Kowalsky
- Chief Legal Officer and Corporate Secretary
- --
- Brendan Luu
- Chief Business Officer
- --
- Dr. Yat Sun Or, PhD
- Chief Scientific Officer
- 1.22M
- Dr. Scott T. Rottinghaus, M.D.
- Chief Medical Officer
- 1.26M
- Dr. Tara Lynn Kieffer, PhD
- Chief Product Strategy Officer
- --
- Paul J. Mellett
- Chief Financial Officer, Principal Accounting Officer and Chief Administrative Officer
- 1.14M
- Dr. Bruce L.A. Carter,PhD
- Non-Executive Chairman of the Board
- 353.91K
- Dr. Lesley Russell, M.R.C.P.,MB.Ch.B.
- Independent Director
- 321.41K
- Kristine Peterson
- Independent Director
- 326.41K
- Mark G. Foletta
- Independent Director
- 331.41K
- Yujiro S. Hata
- Independent Director
- 318.91K
- Terry C. Vance
- Independent Director
- 333.91K
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.